Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  London Stock Exchange  >  GlobalData Plc    DATA   GB00B87ZTG26

GLOBALDATA PLC

(DATA)
  Report
SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector news

GlobalData : Use of telemedicine to surge in US as regulations change in response to coronavirus

share with twitter share with LinkedIn share with facebook
share via e-mail
03/20/2020 | 11:04am EDT
20 Mar 2020
Use of telemedicine to surge in US as regulations change in response to coronavirus
Posted in Coronavirus

Use of telemedicine in the US has been low to date. However, it is expected that demand for these services will increase dramatically over the next few months due to the coronavirus (COVID-19) crisis, says GlobalData, a leading data and analytics company.

Telemedicine has been touted as a critical strategy during the COVID-19 emergency to limit the risk of person-to-person transmission of the virus, prevent emergency rooms from being inundated, reduce barriers to screening, and allowing those with moderate symptoms to be treated from home. Teladoc Health, a telehealth provider, announced that patient visit volume had increased by 50% since the previous week and was continuing to rise.

Kathryn Whitney, MSc, Director of Thematic Analysis at GlobalData, comments: 'Prior to the COVID-19 crisis, telemedicine had never reached its full potential in the US, with several barriers preventing its widespread uptake. These include lack of reimbursement and restrictions affecting access for rural populations, general lack of awareness of these services, and the desire of the sick to see their physician in person.'

Since early March, regulations in the US governing the use of telemedicine have changed regularly, which will expand access to services during the COVID-19 emergency, particularly for Medicare beneficiaries who are deemed at high risk for the virus. In certain states, including California and New York, officials have also announced that payers must offer telehealth services as part of their emergency plans. In Massachusetts, payers must cover the COVID-19 testing and treatment via telehealth, and cannot impose cost sharing via co-pays, deductibles, or coinsurance, and prior authorization is not required to receive treatment via telehealth.

Whitney continues: 'Recent changes to regulations by the US Government will remove many of the financial barriers to telehealth and drive the use of these services, particularly among older and vulnerable populations. People will also become more aware of these types of services, given amount of information being disseminated by the government, hospitals, healthcare systems and payers.

'As more US cities and states begin to lock down and social distancing becomes the new normal for the foreseeable future, Americans are likely to change their views on telemedicine. With the ongoing risk of virus transmission, people will be eager to avoid hospitals and get screened and receive care from the safety of their own homes.'

Disclaimer

GlobalData plc published this content on 20 March 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 20 March 2020 16:03:08 UTC

share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news on GLOBALDATA PLC
08:43aGLOBALDATA : Global gas flaring value approaches US$24bn a year if priced at Eur..
PU
08:23aGLOBALDATA : New incentives and benefits can boost R&D ecosystem for new drug de..
PU
03/27GLOBALDATA : Novartis' Zolgensma expected to generate global sales of $2.5bn by ..
PU
03/26GLOBALDATA : Goodyear's sentiments slide in Q4 2019 due to challenging environme..
PU
03/26GLOBALDATA : Permian production already a victim of oil price war
PU
03/26GLOBALDATA : Sparkling wine emerged as most mentioned wine category among indust..
PU
03/26GLOBALDATA PLC : Ex-dividend day for final dividend
FA
03/25GLOBALDATA : Amid Covid-19 outbreak GlobalData suggests short-term and long-term..
PU
03/24GLOBALDATA : Telecom equipment companies must minimize risks to the supply chain..
AQ
03/23GLOBALDATA : Coronavirus outbreak derails IPOs
PU
More news
Financials (GBP)
Sales 2020 186 M
EBIT 2020 48,8 M
Net income 2020 23,0 M
Debt 2020 35,1 M
Yield 2020 1,58%
P/E ratio 2020 59,7x
P/E ratio 2021 45,0x
EV / Sales2020 6,99x
EV / Sales2021 6,54x
Capitalization 1 268 M
Chart GLOBALDATA PLC
Duration : Period :
GlobalData Plc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends GLOBALDATA PLC
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus UNDERPERFORM
Number of Analysts 2
Average target price 1 200,00  GBp
Last Close Price 1 075,00  GBp
Spread / Highest target 11,6%
Spread / Average Target 11,6%
Spread / Lowest Target 11,6%
EPS Revisions
Managers
NameTitle
Michael Thomas Danson Chief Executive Officer & Director
Bernard Anthony Cragg Chairman
Sally Kate Miranda Johnson Chief Financial Officer
Peter Martin Harkness Independent Non-Executive Director
Murray Legg Non-Executive Director
Sector and Competitors
1st jan.Capitalization (M$)
GLOBALDATA PLC-16.67%1 574
S&P GLOBAL INC.-12.20%57 707
RELX PLC-11.13%40 475
THOMSON REUTERS CORPORATION-6.28%30 623
WOLTERS KLUWER-8.31%17 577
EQUIFAX INC.-14.68%14 582